Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer–A Pilot Study

RATIONALE AND OBJECTIVES: To explore a role for multiparametric MRI (mpMRI) as a biomarker of response to neoadjuvant androgen deprivation therapy (ADT) for prostate cancer (PCa). MATERIALS AND METHODS: This prospective study was approved by the institutional review board and was HIPAA compliant. Ei...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Acad Radiol
Main Authors: Fennessy, Fiona M., Fedorov, Andriy, Vangel, Mark G., Mulkern, Robert V., Tretiakova, Maria, Lis, Rosina T., Tempany, Clare, Taplin, Mary-Ellen
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297658/
https://ncbi.nlm.nih.gov/pubmed/31862185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.acra.2019.10.017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares